Clinical trial · Interventional
Anal Injury Screening for High Risk HPV
Anal Injury Screening for High Risk HPV in Population With Susceptibility to Anal Cancer Development
NCT04512508CI-TRIAL-00046606AnalTestunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The diagnosis of anal cancer is superior with the Anal Test system compared to liquid cytology and anoscopy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anal Cancer | Malignant Anal Neoplasm | CURATED_EXACT | 0.92 |
| Anal Injury | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Self test sample | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Group 1, HIV negative patients.
- description
- Only HIV negative patients
- interventionNames
- Diagnostic Test: Self test sample
- type
- OTHER
- label
- Group 2, HIV positive patients
- description
- Only HIV positive patients
- interventionNames
- Diagnostic Test: Self test sample
Primary outcomes (1)
- measure
- Percentage of positive results for Anal Test system versus anal liquid cytology and anoscopy for the presence of high-risk human papillomaviruses
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Men and women between 30 and 65 years old. * They agree to participate in the study and sign informed consent. * They have not received previous treatments for HPV or had previous intraepithelial lesions or anal cancer. * Immunosuppressed patients. * Women with LIAG of the genital tract (cervix, vagina, or vulva). * Patients who have had anal intercourse Exclusion Criteria: * Patients sexually inactive * Subjects who had anal sex in less than 24 hours prior to the study. * Patients with local medication application (enemas, suppositories).
References
Publications (0)
Data not yet available
No reference posted for this study.